You won't want to miss this at #ESCMIDGlobal 2025! Join Dr. @jshiaurx.bsky.social and team as they share their translational expertise on renal injury markers! Get the skim on KIM-1! 💉 @idpharmacometrx.bsky.social

41/47 (87%) of NIH study sections are cancelled this week Frustrating to see all this good research stalled (& not funded) You can search for study sections that ‘did not meet as scheduled’ here with ones with * ⤵️ www.csr.nih.gov/RevPanelsAnd...

Out in OFID today. Why just looking at trough alone is not enough for monitoring vancomycin. Great work from our fellow Dr. Shiau and in collaboration with Drs. Roy and Sabourenkov from DoseMe. academic.oup.com/ofid/advance...

Poster notifications are out!

Since I am freed from thinking about all NIH science things for at least another week, I have begun planning what research might look like under the new agenda. Behold! My seminal discoveries on the PK/PD of homeopathy:

Scientists and Physicians I’m being serious here —at this precarious juncture, along with all other defensive and support strategies, it is important to seize the public narrative—high level investment and leadership in medical discovery and innovation is unabashedly patriotic! USA! USA! USA!

Really excited by this article from @idpharmacometrx.bsky.social et al. Protamine as the prototype for megalin blockade to reduce/delay kidney accumulation of vanc (and maybe colistin and aminoglycosides…). But also an excellent VIKI overview, fab pics 💕 journals.asm.org/doi/10.1128/...

“The impact of the collective executive orders and directives appears devastating.” scim.ag/40ureTO

Excited for: @escmid.bsky.social ... I see the countdown. :) This is also the countdown of ~ how long it takes some in the US to get international travel approval. Any direct guidance on when abstract disposition will be available?

Pharmacists- Want to take the next step in research? Check out @ACCP FIT&MERIT programs. FIT was transformational for me. There is a lot to know about doing research (MERIT) and writing a grant (FIT) that isn't easily accessible. See behind the curtain. www.accp.com/report/index...

Can we please stop meta-analyzing Vancomycin + Pip/Tazo and start trials looking at: 1) real time GFR measurements 2) injury biomarkers 3) progression to RRT (in a prospective manner). Meta-analysis is good as a stop gap. It is time to fill the gap. pmc.ncbi.nlm.nih.gov/articles/PMC...

The California fires are obviously horrible. In the Infectious Diseases and Pharmacometrics community, our colleague @mnneely lost his house. His family is safe, but if you wish to contribute to helping him get his life back to normal, you can do so here: www.gofundme.com/f/help-the-n...

Merry Christmas!

Appropriate day for the Uni to shut down for the holiday:

You know that you are a dork when this excites you. Finally got the assay working, just before the lab close for the holidays. Merry Christmas, Happy Holidays, and Happy New Year!

The USCAST most recent antimicrobial susceptibility testing proposals are now open for public comment. Check out the website for recent presentations and the data behind the recommendation. We'd love to hear public comments on the proposed susceptibility changes. www.uscast.org

You know what doesn't work? MDPI unsubscribe.

Thanks for hosting @stanggirdwood.bsky.social and presenting Nieko!!! Wonderful to meet many of these people in person. #precisiondosing (Is hash-tagging a thing in here??)

@idpharmacometrx.bsky.social Welcome to #idsky #pkpdsky